Using immunotherapy to enhance the response of a C3H mammary carcinoma to proton radiation
Author:
Affiliation:
1. Experimental Clinical Oncology-Dept. Oncology, Aarhus University Hospital, Aarhus, Denmark
2. Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark
Funder
the Danish National Board of Health’s research pool to strengthen research in immunotherapy of cancer
Danish Cancer Society
This work was supported by Kræftens Bekæmpelse
The Danish National Board of Health’s research pool to strengthen research in immunotherapy
Publisher
Medical Journals Sweden AB
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2238550
Reference36 articles.
1. Next steps in immuno-oncology: enhancing antitumor effects through appropriate patient selection and rationally designed combination strategies
2. Cancer immunoediting: from immunosurveillance to tumor escape
3. CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic
4. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
5. De-novo and acquired resistance to immune checkpoint targeting
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical application of high‐LET radiotherapy combined with immunotherapy in malignant tumors;Precision Radiation Oncology;2024-03
2. Think big–think BiGART. The 21st Acta Oncologica Symposium—BiGART 2023;Acta Oncologica;2023-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3